Oncopeptides’ Pepaxto Withdrawal Speeds Through In 7 Months Under Expedited Procedures

 
• By Sue Sutter, Nancy Pham, and Kosh Naran
  
Foot race
Pepaxto marked the fastest accelerated approval withdrawal from CDER proposal to final agency order. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Post-Marketing Regulation & Studies

More from Product Reviews